Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Stepping up to payer-driven market access

Giving the industry an opportunity to secure payers’ endorsements of its products by clearly illustrating product value

Bristol Myers Squibb logo

Opdivo boosts survival in head and neck cancer by 30%

Pivotal trial of BMS’ PD-1 inhibitor shows "significant benefit" in overall survival

Boehringer Ingelheim Professor Andreas Barner

Boehringer Ingelheim returns to growth after US turnaround

But expects only a minor sales increase during a transitional 2016

- PMLiVE

Remicade safe from biosimilar competition this year, says J&J

Will defend the blockbuster’s US patents should Celltrion's Inflectra launch in 2016

- PMLiVE

Focusing on value

Merck’s Consumer Health head Uta Kemmerich-Keil on how she wants to add value to her business and society at large

How to add credibility to your customer communication

For really compelling – and credible – digital communication, there’s a factor beyond traditional emotional appeals and logical arguments that’s often forgotten. And for pharma, it’s a must have.

Anthill Agency

- PMLiVE

New biosimilars group will tackle slow uptake in UK

Has pledged to increase access to lower-priced versions of biologic drugs

Dr Jay Stout moves from Merck to SanBio

He joins as senior vice president of manufacturing

- PMLiVE

Should we be concerned about medical progress?

Medical progress, health expenditure, ageing populations and the future of our healthcare systems

Maxor appoints new chief executive officer

Mike Ellis succeeds John Ward

- PMLiVE

FDA approves expanded indication for Gilotrif

US body gives Boehringer Ingelheim’s oral lung cancer treatment the nod

- PMLiVE

AbbVie hepatitis C combo shows high cure rates

Presents promising new phase II data across all six major HCV genotypes

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links